{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T20:19:02Z","timestamp":1771877942332,"version":"3.50.1"},"reference-count":38,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Bonn"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: The PreserFlo\u2122 MicroShunt (PFMS) is a bleb-forming device considered to be less invasive than traditional glaucoma surgery such as trabeculectomy. This study evaluates the 1-year success rates as well as safety profile of PFMS in patients having high intraocular pressure (IOP) and\/or glaucoma refractory to drop therapy with a history of prior intravitreal dexamethasone therapy. Methods: A total of 16 eyes after PFMS implantation due to elevated IOP after intravitreal dexamethasone implant (DEX-I) administration were included in this retrospective cohort study. Success rates and secondary outcomes were evaluated. Results: Qualified and complete success rates at 12 months, respectively, were 14\/16 and 12\/16 eyes for criterion A, 13\/16 and 11\/16 eyes for B, 13\/16 and 11\/16 eyes for C, and 6\/16 and 6\/16 eyes for D. The overall mean (range) preoperative IOP decreased from 27 (16\u201338) mmHg to 13 (10\u201317) mmHg at 12 months. BCVA was not significantly different up to 12 months (p = 0.63). The preoperative mean (range) number of medications decreased from 3.56 (2\u20134) to 0.31 (0\u20133) at 12 months. One eye underwent needling twice, and two eyes were revised surgically. One patient needed replacement of the PFMS. There were no hypotony-related complications. Conclusions: The PFMS is an effective surgical option for patients with steroid-induced IOP elevation. It demonstrates satisfactory short-term success rates, a reduced need for pressure-lowering eye drops, an excellent safety profile with minimal postoperative care, and a low complication rate. Additional interventions such as needling or revisions were infrequently necessary. However, PFMS may not be the ideal choice for cases requiring a low target pressure (\u226412 mmHg).<\/jats:p>","DOI":"10.3390\/jcm14020507","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T13:49:32Z","timestamp":1736862572000},"page":"507","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Short-Term Safety and Efficacy of PreserFlo\u2122 Microshunt in Patients with Refractory Intraocular Pressure Elevation After Dexamethasone Implant Intravitreal Injection"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8498-7396","authenticated-orcid":false,"given":"Leonie","family":"Bourauel","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, University of Bonn, 53127 Bonn, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Petrak","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Bonn, 53127 Bonn, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank G.","family":"Holz","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Bonn, 53127 Bonn, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Mercieca","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Bonn, 53127 Bonn, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constance","family":"Weber","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Bonn, 53127 Bonn, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The Number of People with Glaucoma Worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","article-title":"Global Causes of Blindness and Distance Vision Impairment 1990\u20132020: A Systematic Review and Meta-Analysis","volume":"5","author":"Flaxman","year":"2017","journal-title":"Lancet Glob. Health"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.ophtha.2019.04.012","article-title":"Primary Selective Laser Trabeculoplasty for Open-Angle Glaucoma and Ocular Hypertension: Clinical Outcomes, Predictors of Success, and Safety from the Laser in Glaucoma and Ocular Hypertension Trial","volume":"126","author":"Garg","year":"2019","journal-title":"Ophthalmology"},{"key":"ref_4","unstructured":"(2017). Glaucoma: Diagnosis and Management NICE Guideline, National Institute for Health and Care Excellence."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40662-019-0154-1","article-title":"Micro-Invasive Glaucoma Surgery\u2014An Interventional Glaucoma Revolution","volume":"6","author":"Shah","year":"2019","journal-title":"Eye Vis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/rb\/rbw005","article-title":"The Use of Poly(Styrene-Block-Isobutyleneblock-Styrene) as a Microshunt to Treat Glaucoma","volume":"3","author":"Pinchuk","year":"2016","journal-title":"Regen. Biomater."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1136\/bjophthalmol-2021-319062","article-title":"Effect of COVID-19 Pandemic on Glaucoma Surgical Practices in the UK","volume":"106","author":"Holland","year":"2022","journal-title":"Br. J. Ophthalmol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.ophtha.2021.05.023","article-title":"Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: One-Year Results from a 2-Year Randomized, Multicenter Study","volume":"128","author":"Baker","year":"2021","journal-title":"Ophthalmology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1097\/IJG.0000000000000368","article-title":"Three-Year Follow-up of a Novel Aqueous Humor Microshunt","volume":"25","author":"Batlle","year":"2016","journal-title":"J. Glaucoma"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ogla.2021.07.008","article-title":"Safety and Effectiveness of the PRESERFLO\u00ae MicroShunt in Primary Open-Angle Glaucoma: Results from a 2-Year Multicenter Study","volume":"5","author":"Beckers","year":"2022","journal-title":"Ophthalmol. Glaucoma"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1016\/j.ophtha.2011.05.014","article-title":"Dexamethasone Intravitreal Implant in Patients with Macular Edema Related to Branch or Central Retinal Vein Occlusion: Twelve-Month Study Results","volume":"118","author":"Haller","year":"2011","journal-title":"Ophthalmology"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Vitiello, L., Salerno, G., Coppola, A., De Pascale, I., Abbinante, G., Gagliardi, V., Lixi, F., Pellegrino, A., and Giannaccare, G. (2024). Switching to an Intravitreal Dexamethasone Implant after Intravitreal Anti-VEGF Therapy for Diabetic Macular Edema: A Review. Life, 14.","DOI":"10.3390\/life14060725"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.2147\/OPTH.S79948","article-title":"Dexamethasone Intravitreal Implant in the Treatment of Diabetic Macular Edema","volume":"9","author":"Dugel","year":"2015","journal-title":"Clin. Ophthalmol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"585","DOI":"10.4103\/ijo.IJO_684_21","article-title":"Secondary Glaucoma after Intravitreal Dexamethasone Implant (Ozurdex) Injection in Patients with Retinal Disorder: A Retrospective Study","volume":"70","author":"Sweta","year":"2022","journal-title":"Indian J. Ophthalmol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/bjophthalmol-2019-313991","article-title":"Safety of 6000 Intravitreal Dexamethasone Implants","volume":"104","author":"Rajesh","year":"2020","journal-title":"Br. J. Ophthalmol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1097\/IAE.0000000000001004","article-title":"Intraocular Pressure in Patients with Diabetic Macular Edema Treated with Dexamethasone Intravitreal Implant in the 3-Year Mead Study","volume":"36","author":"Maturi","year":"2016","journal-title":"Retina"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1007\/s00417-023-06163-5","article-title":"Incidence and Treatment Approach of Intraocular Pressure Elevation After Various Types of Local Steroids for Retinal Diseases","volume":"261","author":"Wykrota","year":"2023","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/IJG.0000000000002183","article-title":"Gonioscopy-Assisted Transluminal Trabeculotomy and Goniotomy, With or Without Concomitant Cataract Extraction, in Steroid-Induced and Uveitic Glaucoma: 24-Month Outcomes","volume":"32","author":"Chen","year":"2023","journal-title":"J. Glaucoma"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1159\/000522504","article-title":"Incidence, Risk Factors, Treatment, and Outcome of Ocular Hypertension Following Intravitreal Steroid Injections: A Comparative Study","volume":"245","author":"Badrinarayanan","year":"2022","journal-title":"Ophthalmologica"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jcjo.2021.05.006","article-title":"Selective Laser Trabeculoplasty in Steroid-Induced and Uveitic Glaucoma","volume":"57","author":"Zhou","year":"2022","journal-title":"Can. J. Ophthalmol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"656","DOI":"10.18240\/ijo.2023.04.22","article-title":"Refractory Intraocular Hypertension after Dexamethasone-Implant Intravitreal Injection Treated with Preserflo MicroShunt Implantation","volume":"16","author":"Sejournet","year":"2023","journal-title":"Int. J. Ophthalmol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ogla.2023.04.002","article-title":"Ab Externo SIBS Microshunt with Mitomycin C for Open-Angle Glaucoma: Three-Year Results as a Primary Surgical Intervention","volume":"6","author":"Armstrong","year":"2023","journal-title":"Ophthalmol. Glaucoma"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1038\/s41433-022-02368-w","article-title":"Preserflo Microshunt Implant for the Treatment of Refractory Uveitic Glaucoma: 36-Month Outcomes","volume":"37","author":"Triolo","year":"2023","journal-title":"Eye"},{"key":"ref_24","unstructured":"Shaarawy, T.M. (2009). Guidelines on Design and Reporting of Glaucoma Surgical Trials, Kugler Publications."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/s41433-022-01995-7","article-title":"Short-Term Safety and Efficacy of PreserFlo\u2122 Microshunt in Glaucoma Patients: A Multicentre Retrospective Cohort Study","volume":"37","author":"Bhayani","year":"2023","journal-title":"Eye"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.survophthal.2020.01.002","article-title":"Steroid-Induced Glaucoma: Epidemiology, Pathophysiology, and Clinical Management","volume":"65","author":"Roberti","year":"2020","journal-title":"Surv. Ophthalmol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.2147\/OPTH.S402142","article-title":"Treatment of Diabetic Macular Edema or Macular Edema Following Retinal Vein Occlusion Based on Repeated Injection of the Dexamethasone Intravitreal Implant: A Retrospective Real-World Analysis","volume":"17","author":"Sanders","year":"2023","journal-title":"Clin. Ophthalmol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00417-016-3472-1","article-title":"A Multicenter, 12-Month Randomized Study Comparing Dexamethasone Intravitreal Implant with Ranibizumab in Patients with Diabetic Macular Edema","volume":"255","author":"Callanan","year":"2017","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1097\/IAE.0000000000001883","article-title":"Intraocular Dexamethasone Implant Position In Situ and Ocular Hypertension","volume":"38","author":"Sudhalkar","year":"2018","journal-title":"Retina"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s00417-023-06012-5","article-title":"Circumferential (360\u00b0) Trabeculotomy for Steroid-Induced Glaucoma in Adults","volume":"261","author":"Eggink","year":"2023","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1007\/s00417-022-05725-3","article-title":"Use of Selective Laser Trabeculoplasty as an Alternative in Patients Who Developed Ocular Hypertension After Intravitreal Dexamethasone Implants: A Series of 35 Eyes","volume":"260","author":"Billant","year":"2022","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3182935","DOI":"10.1155\/2017\/3182935","article-title":"Safety and Efficacy of Microinvasive Glaucoma Surgery","volume":"2017","author":"Chen","year":"2017","journal-title":"J. Ophthalmol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jcjo.2020.06.021","article-title":"Ocular Hypertension Following 40 Mg Sub-Tenon Triamcinolone Versus 0.7 Mg Dexamethasone Implant Versus 2 Mg Intravitreal Triamcinolone","volume":"55","author":"Kuley","year":"2020","journal-title":"Can. J. Ophthalmol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"9215650","DOI":"10.1155\/2018\/9215650","article-title":"Outcome of Primary Nonpenetrating Deep Sclerectomy in Patients with Steroid-Induced Glaucoma","volume":"2018","author":"Elhofi","year":"2018","journal-title":"J. Ophthalmol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ophtha.2009.06.014","article-title":"Moving the Goal Posts. Definitions of Success after Glaucoma Surgery and Their Effect on Reported Outcome","volume":"117","author":"Rotchford","year":"2010","journal-title":"Ophthalmology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"100054","DOI":"10.1016\/j.ajoint.2024.100054","article-title":"3-Year Safety and Efficacy Results of PreserFlo\u2122 Microshunt in Glaucoma Patients: A Multicentre European Cohort Study","volume":"1","author":"Mercieca","year":"2024","journal-title":"AJO Int."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ajo.2023.06.009","article-title":"All Consecutive Ab Externo SIBS Microshunt Implantations with Mitomycin C: One-Year Outcomes and Risk Factors for Failure","volume":"255","author":"Schlenker","year":"2023","journal-title":"Am. J. Ophthalmol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1097\/IAE.0000000000001369","article-title":"Safety of Intravitreal Dexamethasone Implant (Ozurdex). The SAFODEX Study. Incidence and Risk Factors of Ocular Hypertension","volume":"37","author":"Dot","year":"2017","journal-title":"Retina"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/2\/507\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:28:51Z","timestamp":1759919331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/2\/507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,14]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["jcm14020507"],"URL":"https:\/\/doi.org\/10.3390\/jcm14020507","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,14]]}}}